2026. Not All Bruton’s Tyrosine Kinase Inhibitors are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-covalent BTK Inhibitors. Actualité hématologique au Canada. 5, s02 (mai 2026), 2–7. DOI:https://doi.org/10.58931/cht.2026.5s0282.